It's tricky, because between condoms, PREP and PEP (pre- and post-exposure drugs) and treatments now being good enough that life expectancy with HIV is nearly the same as without, it'd take very low risks of side effects before giving it to everyone would cause more harm than not giving it.

So the safety profile will be hugely important in determining how widely to use it.